Analgesics in Bosnia-herzegovina - New Market Research Report
Bosnia-Herzegovina did not see any initiatives to review OTC status or dosage strengths of certain analgesic categories. Relative to the performance recorded over the review period, analgesics' performance in 2011 was weaker. This was due to the reduced disposable income of consumers in Bosnia-Herzegovina as a result of the recession.
View full press release